Search results for "From ACP Internist"
Get comfortable talking about obesity
In this month's Pearls from I.M. Peers, a new video feature from ACP Internist, Kimberly N. Sims, MD, FACP, explained ways to make obesity counseling easier for patients and for their doctors.
https://gastroenterology.acponline.org/archives/2022/04/22/9.htm
22 Apr 2022
Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD
A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.
https://gastroenterology.acponline.org/archives/2022/10/28/8.htm
28 Oct 2022
Guideline suggests prescription medications when lifestyle change ineffective for weight loss
For adults with obesity or overweight with weight-related complications, the American Gastroenterological Association found moderate certainty of benefit for four medications: semaglutide, liraglutide, phentermine-topiramate ER, or naltrexone-bupropion.
https://gastroenterology.acponline.org/archives/2022/10/28/6.htm
28 Oct 2022
About one-third of Americans with HCV had evidence of viral clearance in past decade
The highest proportion of hepatitis C virus (HCV) cure or clearance among all age groups and payers was 49% among commercially insured patients ages 60 years and older, a study found.
https://gastroenterology.acponline.org/archives/2023/07/28/6.htm
28 Jul 2023
Studies show mixed results for artificial intelligence during colonoscopies
One study found a higher adenoma detection rate in patients who underwent computer-aided detection compared to standard colonoscopy, while another found that artificial intelligence did not improve identification of advanced colorectal neoplasias.
https://gastroenterology.acponline.org/archives/2023/09/22/6.htm
22 Sep 2023
ACG updates, reaffirms guidelines on evaluation, management of patients with celiac disease
The diagnostic approach to celiac disease in adults using serological and histologic data remains unchanged from the American College of Gastroenterology's (ACG) 2013 clinical guidelines.
https://gastroenterology.acponline.org/archives/2023/01/27/6.htm
27 Jan 2023
AGA clinical practice update offers guidance on PPI deprescribing
All patients taking a proton-pump inhibitor (PPI) should have a regular review and documentation of ongoing indications for use, which should be the responsibility of the primary care clinician, the American Gastroenterological Association (AGA) said.
https://gastroenterology.acponline.org/archives/2022/02/25/6.htm
25 Feb 2022
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://gastroenterology.acponline.org/archives/2022/11/18/6.htm
18 Nov 2022
Long-term PPI use associated with higher incidence of dementia
While patients who took proton-pump inhibitors (PPIs) from mid- to late life had a modestly higher risk of dementia in late life versus nonusers, shorter-term use was not associated with increased risk.
https://gastroenterology.acponline.org/archives/2023/08/25/7.htm
25 Aug 2023
ID, liver societies update guidance for HCV testing, management
Major changes to guidance on hepatitis C virus (HCV) include an emphasis on universal screening, new recommendations for managing incomplete treatment adherence, and expansion of treatment eligibility, among others.
https://gastroenterology.acponline.org/archives/2023/06/23/6.htm
23 Jun 2023